.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Acetaminophen (APAP) is a common analgesic in India, yet its overdose frequently leads to drug-induced acute liver failure. Researchers have recently identified cordycepin hepatoprotective effects as a potential therapeutic breakthrough for this clinical challenge. This bioactive compound, sourced from the edible fungus Cordyceps militaris, exhibits powerful antioxidant and anti-inflammatory properties that preserve hepatocyte integrity during toxic metabolic stress.
The study utilized mouse models to investigate how cordycepin pretreatment affects liver recovery after high-dose paracetamol exposure. Specifically, researchers observed that administering this fungal derivative significantly decreased serum transaminase levels, which are critical biomarkers of liver cell death. Furthermore, histological assessments confirmed a marked reduction in hepatic necrosis and a decrease in inflammatory cell infiltration in the treated groups.
Moreover, the underlying mechanism involves the sophisticated regulation of endoplasmic reticulum (ER) proteostasis. Cordycepin appears to coordinate signaling through the HIF-1 and PPAR pathways to maintain cellular equilibrium. Consequently, these cordycepin hepatoprotective effects prevent the programmed cell death of hepatocytes typically triggered by paracetamol metabolites. Unlike conventional single-target therapies, this natural compound offers a multi-faceted approach to preventing chemical-induced organ damage.
Transcriptomic analysis showed that cordycepin successfully reverses the expression of key genes linked to oxidative damage and inflammatory responses. While N-acetylcysteine (NAC) currently serves as the standard clinical antidote, it often faces limitations due to its narrow therapeutic window. Therefore, exploring natural hepatoprotective agents like cordycepin could provide a valuable adjunct for managing acute liver injuries. However, clinicians must wait for robust human clinical trials to define exact dosage requirements and long-term safety profiles.
Cordycepin is a primary bioactive nucleoside found in the medicinal mushroom Cordyceps militaris, which has long been valued for its anti-inflammatory and immune-modulating properties.
It safeguards the liver by mitigating oxidative stress, suppressing pro-inflammatory cytokines, and restoring ER proteostasis to prevent hepatocyte apoptosis.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Always consult a qualified medical professional for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Fu C et al. Edible Fungus Compound Cordycepin Protects Against Acetaminophen-Induced Liver Injury. J Clin Lab Anal. 2026 May 25. doi: 10.1002/jcla.70266. PMID: 42184123.
Ding J et al. Cordycepin Protects against Hepatic Ischemia/Reperfusion Injury via Inhibiting MAPK/NF-κB Pathway. Gastroenterology. 2014;147(4):765-783.
Kaur K et al. To Study Hepatoprotective Potential of Genius Cordyceps. Journal of Advance and Future Research. 2026 May 20;4(5).
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study demonstrates that cordycepin, a compound from Cordyceps militaris, mitigates acetaminophen-induced liver injury by modulating ER stress pathways....
3 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
